Cargando…

ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells

Comprehensive immune monitoring requires that frequencies of T cells, producing different cytokines, are measured to establish the magnitude of Th1, Th2, and Th17 components of cell-mediated immunity. Antigen titration provides additional information about the affinity of T cell response. In tumor i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanson, Jodi, Sundararaman, Srividya, Caspell, Richard, Karacsony, Edith, Karulin, Alexey Y., Lehmann, Paul V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381210/ https://www.ncbi.nlm.nih.gov/pubmed/25643292 http://dx.doi.org/10.3390/cells4010071

Ejemplares similares

ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting
por: Karulin, Alexey Y., et al.
Publicado: (2015)

User vs. software-dependent variability of ELISPOT counts obtained from ten different laboratories
por: Ansari, Tameem, et al.
Publicado: (2013)

Normal Distribution of CD8+ T-Cell-Derived ELISPOT Counts within Replicates Justifies the Reliance on Parametric Statistics for Identifying Positive Responses
por: Karulin, Alexey Y., et al.
Publicado: (2015)

ELISPOTs produced by CD8 and CD4 cells follow log normal size distribution
por: Ghosh, Jaya, et al.
Publicado: (2013)

Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity
por: Wunsch, Marie, et al.
Publicado: (2015)

High Reproducibility of ELISPOT Counts from Nine Different Laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2015)

Log-Normal ELISPOT spot size distribution permits count harmonization among different laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2014)

Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays
por: Kuerten, Stefanie, et al.
Publicado: (2012)

Mobilization permits reliable ELISPOT detection of long-term memory T cells secreting IFN-γ, IL-4, IL-5, and IL-17 without in vitro expansion
por: Ghosh, Jaya, et al.
Publicado: (2013)

Imaging-based, non-radioactive measurements of natural killer cell activity provides comparable results as classic chromium release assays but with fewer cells and less labor
por: Sundararaman, Srividya, et al.
Publicado: (2014)

Four color B cell immunospot assays for simultaneous detection of all four immunoglobulin classes and subclasses
por: Caspell, Richard, et al.
Publicado: (2014)

Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay
por: Wunsch, Marie, et al.
Publicado: (2015)

High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated Cytotoxicity
por: Welter, Anna, et al.
Publicado: (2018)

Does the number of apoptotic cells in PBMC reveal the extent of impairment in T cell functionality?
por: Sundararaman, Srividya, et al.
Publicado: (2013)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
por: Anthony, Donald D., et al.
Publicado: (2012)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
por: Kalyuzhny, Alexander E.
Publicado: (2011)

An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi
por: Jin, Chenggang, et al.
Publicado: (2013)

B Cells and B Cell Blasts Withstand Cryopreservation While Retaining Their Functionality for Producing Antibody
por: Fecher, Philipp, et al.
Publicado: (2018)

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020)

Defining ELISpot cut-offs from unreplicated test and control wells
por: Alexander, Neal, et al.
Publicado: (2013)

Analysis of vertebrate vision in a 384-well imaging system
por: Thorn, Robert J., et al.
Publicado: (2019)

Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening
por: Duffy, Sandra, et al.
Publicado: (2012)

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories
por: Gill, Dilbinder K., et al.
Publicado: (2010)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
por: Zitzner, Jennifer R., et al.
Publicado: (2012)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
por: Janetzki, Sylvia, et al.
Publicado: (2014)

Miniaturization and optimization of 384-well compatible RNA sequencing library preparation
por: Mayday, Madeline Y., et al.
Publicado: (2019)

Immune monitoring technology primer: the enzyme-linked immunospot (Elispot) and Fluorospot assay
por: Janetzki, Sylvia
Publicado: (2015)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
por: Nowacki, Tobias M., et al.
Publicado: (2012)

The Granzyme B ELISPOT assay: an alternative to the (51)Cr-release assay for monitoring cell-mediated cytotoxicity
por: Shafer-Weaver, Kimberly, et al.
Publicado: (2003)

Standardization and Validation of Fluorescence-Based Quantitative Assay to Study Human Platelet Adhesion to Extracellular-Matrix in a 384-Well Plate
por: Martins Lima, Augusto, et al.
Publicado: (2020)

Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
por: Shafer-Weaver, Kimberly A, et al.
Publicado: (2004)

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
por: Malyguine, Anatoli M., et al.
Publicado: (2012)

Reagent Tracker Dyes Permit Quality Control for Verifying Plating Accuracy in ELISPOT Tests
por: Lehmann, Alexander, et al.
Publicado: (2018)

Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays
por: Hagen, Jodi, et al.
Publicado: (2015)

Experimental exposure assessment for in vitro cell-based bioassays in 96- and 384-well plates
por: Huchthausen, Julia, et al.
Publicado: (2023)

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
por: Malyguine, Anatoli, et al.
Publicado: (2004)

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells
por: Janetzki, Sylvia, et al.
Publicado: (2009)

Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay
por: Grant, Clare FJ, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0j3l3pg3bh70qanmu8nt8qbde3